Table 1.
Time to start caplacizumab treatment as initial treatment or after refractoriness or exacerbation in days
| N | Median | IQR | P | |
|---|---|---|---|---|
| Initial treatment | 44 | 2 | 1-4 | <.0001 |
| Exacerbation | 19 | 14 | 10-16 | |
| Refractoriness | 14 | 10 | 8-13 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.